206 related articles for article (PubMed ID: 2788981)
1. Development of specific human mab's by a small scale electrofusion technique: the influence of some physical and chemical factors on hybridoma yield of human peripheral blood lymphocytes XCB-F7 fusions.
Glaser RW; Jahn S; Grunow R
Allerg Immunol (Leipz); 1989; 35(2):123-32. PubMed ID: 2788981
[TBL] [Abstract][Full Text] [Related]
2. Strategies in the development of human monoclonal antibodies.
Jahn S; Grunow R; Kiessig ST; Settmacher U; Von Baehr R
Dev Biol Stand; 1990; 71():3-7. PubMed ID: 2401386
[TBL] [Abstract][Full Text] [Related]
3. Efficient electric field-induced generation of hybridomas from human B lymphocytes without prior activation in vitro.
Kwekkeboom J; de Groot C; Tager JM
Hum Antibodies Hybridomas; 1992 Jan; 3(1):48-53. PubMed ID: 1576322
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three human-murine heteromyeloma cell lines for formation of human hybridomas after electrofusion with human peripheral blood lymphocytes from meningococcal cases and carriers.
Delvig AA; Koumaré B; Glaser RW; Wang JF; Jahn S; Achtman M
Hum Antibodies Hybridomas; 1995; 6(2):42-6. PubMed ID: 7492749
[TBL] [Abstract][Full Text] [Related]
5. Development of specific IgG-producing human hybridomas by fusions of lymphocytes from actively immunized persons.
Jahn S; Settmacher U; Haensel K; Kiessig S; Grunow R; Von Baehr R
Hybridoma; 1989 Oct; 8(5):529-33. PubMed ID: 2680900
[TBL] [Abstract][Full Text] [Related]
6. SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus.
Gustafsson B; Jondal M; Sundqvist VA
Hum Antibodies Hybridomas; 1991 Jan; 2(1):26-32. PubMed ID: 1651784
[TBL] [Abstract][Full Text] [Related]
7. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte surface marker expression on hybridomas secreting human monoclonal antibodies.
Seifert M; Jahn S; Schwab J; Döcke W; Volk HD; von Baehr R
Hum Antibodies Hybridomas; 1992 Apr; 3(2):86-92. PubMed ID: 1633269
[TBL] [Abstract][Full Text] [Related]
9. Immunization of SCID-Hu mice and generation of anti-hepatitis B surface antigen-specific hybridomas by electrofusion.
Neil GA; Sammons DW
Hum Antibodies Hybridomas; 1992 Oct; 3(4):201-5. PubMed ID: 1477301
[TBL] [Abstract][Full Text] [Related]
10. Cell activation by CpG ODN leads to improved electrofusion in hybridoma production.
Kato M; Sasamori E; Chiba T; Hanyu Y
J Immunol Methods; 2011 Oct; 373(1-2):102-10. PubMed ID: 21878337
[TBL] [Abstract][Full Text] [Related]
11. Immortalization of magnetically separated human lymphocytes by electrofusion.
Glaser RW; Volk HD; Liebenthal C; Jahn S; Grunow R
Hum Antibodies Hybridomas; 1990; 1(2):111-4. PubMed ID: 1715775
[TBL] [Abstract][Full Text] [Related]
12. Development of a fusion partner cell line for efficient production of human monoclonal antibodies from peripheral blood lymphocytes.
Kalantarov GF; Rudchenko SA; Lobel L; Trakht I
Hum Antibodies; 2002; 11(3):85-96. PubMed ID: 12454369
[TBL] [Abstract][Full Text] [Related]
13. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
Cote RJ; Morrissey DM; Oettgen HF; Old LJ
Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
[TBL] [Abstract][Full Text] [Related]
14. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
15. Extensive loss of human DNA accompanies loss of antibody production in heteromyeloma hybridoma cells.
Koropatnick J; Pearson J; Harris JF
Mol Biol Med; 1988 Apr; 5(2):69-83. PubMed ID: 3260988
[TBL] [Abstract][Full Text] [Related]
16. Increased human hybridoma formation by electrofusion of human B cells with heteromyeloma SPAM-8 cells.
Panova I; Gustafsson B
Hybridoma; 1995 Jun; 14(3):265-9. PubMed ID: 7590790
[TBL] [Abstract][Full Text] [Related]
17. Production of stable heterohybridomas producing human monoclonal antibodies.
Cooper MD; Kirkpatrick R
Methods Mol Biol; 1995; 45():29-39. PubMed ID: 7550689
[No Abstract] [Full Text] [Related]
18. [Current developments in hybridoma technology].
Osterhaus AD; UytdeHaag AG
Tijdschr Diergeneeskd; 1985 Oct; 110(20):835-9. PubMed ID: 3878011
[TBL] [Abstract][Full Text] [Related]
19. High efficiency creation of human monoclonal antibody-producing hybridomas.
Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA
J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310
[TBL] [Abstract][Full Text] [Related]
20. Stabilizing antibody secretion of human Epstein Barr virus-activated B-lymphocytes with hybridoma formation by electrofusion.
Perkins S; Foung SK
Methods Mol Biol; 1995; 48():295-307. PubMed ID: 8528401
[No Abstract] [Full Text] [Related]
[Next] [New Search]
